Translationally, pre-infusion CD3+ T-cell counts and CD4+/CD8+ ratios offered actionable thresholds for patient stratification (25), while achievement of minimal residual disease negativity by day 28 emerged as a critical early indicator of long-term leukemia-free survival (30). This evidence concerns the gene CD4 and leukemia.